$ADTI

Adapti, Inc.

CIK:0001420924|SEC Filings

Condensed Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
Condensed Statements of Operations - USD ($)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024
Income Statement [Abstract]
Revenues	$ 1,525,695	$ 1,244	$ 3,657,796	$ 4,222
Cost of revenue.	1,464,942		2,798,467
Gross Profit	60,753	1,244	859,329	4,222
Operating Expenses
General and administrative	856,571	6,812	1,494,565	57,292
Amortization expense	1,598,333		1,598,333
Professional fees	332,406	261,951	3,184,199	624,874
Total Operating Expenses	2,787,310	268,763	6,277,097	682,166
Loss from operations	(2,726,557)	(267,519)	(5,417,768)	(677,944)
Other Expense
Other income (expense)
Interest expense	(219,769)	(17,552)	(419,940)	(38,002)
Net Other Expense	(219,769)	(17,552)	(419,940)	(38,002)
Net Loss	$ (2,946,326)	$ (285,071)	$ (5,837,708)	$ (715,946)
Net Loss Per Common Share: Basic	$ (0.37)	$ (0.19)	$ (0.93)	$ (0.48)
Net Loss Per Common Share: Diluted	$ (0.37)	$ (0.19)	$ (0.93)	$ (0.48)
Weighted Average Number of Common Shares Outstanding: Basic	8,069,641	1,494,488	6,274,422	1,498,281
Weighted Average Number of Common Shares Outstanding: Diluted	8,069,641	1,494,488	6,274,422	1,498,281

Condensed Statements of Cash Flows - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
Condensed Statements of Cash Flows - USD ($)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024	Mar. 31, 2025
OPERATING ACTIVITIES:
Net loss	$ (2,946,326)	$ (285,071)	$ (5,837,708)	$ (715,946)	$ (430,875)
Adjustments to reconcile net loss to net cash provided by operating activities:
Stock based compensation			226,095	128,333
Amortization of intangible assets			1,598,333
Issuance of notes payable for outstanding accounts payable			75,082	103,431
Common shares issued against extension of notes payable			72,960
Accounts receivable			89	1,016
Prepaid Expenses			11,432
Contracts receivable			1,332,799
Accrued interest			220,318	38,002
Commissions payable			313,941
Accounts payable and accrued liabilities			616,941	220,124
Net Cash Provided By Operating Activities			(1,369,718)	(225,040)
INVESTING ACTIVITIES:
Proceeds from related party notes payable
Advances Jorgan Development and other related parties			(231,915)
Net Cash Used in Investing Activities			(231,915)
FINANCING ACTIVITIES:
Net cash (payments) proceeds line of credit			(511,272)
Repayment of SBA EIDL Loan			(80,900)
Repayment of related party notes Payable			(250,000)	250,000
Issuance of convertible notes payable			285,000
Issuance of related party convertible notes payable			2,156,000
Net contributions from BSG			35,000
Net Cash Provided by Financing Activities			1,633,828	250,000
Net increase (decrease) in cash			32,195	24,960
Cash, beginning of period			572	702	702
Cash, end of period	$ 32,767	$ 25,662	32,767	25,662	$ 572
Supplemental cash flow information
Cash paid for interest
Cash paid for taxes
Non-cash transactions:
Issuance of warrants for stocks				100,000
Issuance of note payable				103,431
Assets acquired in Business Combination with Ballengee			$ 32,727,984

Condensed Balance Sheets - USD ($)	Dec. 31, 2025	Mar. 31, 2025
Current Assets:
Cash	$ 32,767	$ 572
Accounts receivable	245,890	640
Prepaid expenses	5,716
Contracts receivable- current	3,296,360
ROU Current Asset	300,000
Total Current Assets	3,880,733	1,212
Fixed assets, net
Contracts receivable- long term	3,699,937
ROU Asset - long term	671,855
Net Value of future contracts	17,581,667
Intangible asset - brand name	5,956,401
Total Long Term Assets	27,909,861
TOTAL ASSETS	31,790,593	1,212
Current Liabilities:
Accounts payable and accrued liabilities	1,622,599	525,618
Notes payable, accrued interest	66,377
Commissions payable- current	2,046,529
Line of credit	249,022
Operating lease liability, current	300,000
Total Current Liabilities	5,686,947	1,031,987
Commissions payable- long term	2,054,428
Operating lease liability, long term	671,855
EIDL Loans	7,000	7,000
Total Long - Term Liabilities	12,604,992	7,000
Total Liabilities	18,291,939	1,038,987
Stockholders’ Deficit:
Preferred Stock, par value $0.001, authorized 20,000,000 issued zero at December 31, 2025 and March 31, 2025, respectively
Common stock, $0.001 par value, Authorized 40,000,000,000, 8,098,729 and 1,532,388 shares outstanding at December 31, 2025 and March 31, 2025, respectively	8,099	1,532
Additional paid-in capital	28,840,657	8,473,086
Accumulated deficit	(15,350,102)	(9,512,394)
Total Stockholders’ Deficit	13,498,654	(1,037,775)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	31,790,593	1,212
Nonrelated Party [Member]
Current Liabilities:
Convertible notes payable, accrued interest	291,074	52,745
Related Party [Member]
Current Liabilities:
Convertible notes payable, accrued interest	253,195	211,113
Related party notes payable, accrued interest	259,331	242,511
Due to related party	598,820
Related party convertible notes payable, long term	2,197,052
Related party convertible note Payable-long term	$ 7,674,657